Mark S. Gresnigt

7.7k total citations · 2 hit papers
76 papers, 4.2k citations indexed

About

Mark S. Gresnigt is a scholar working on Infectious Diseases, Epidemiology and Immunology. According to data from OpenAlex, Mark S. Gresnigt has authored 76 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Infectious Diseases, 38 papers in Epidemiology and 25 papers in Immunology. Recurrent topics in Mark S. Gresnigt's work include Antifungal resistance and susceptibility (51 papers), Fungal Infections and Studies (29 papers) and Gut microbiota and health (10 papers). Mark S. Gresnigt is often cited by papers focused on Antifungal resistance and susceptibility (51 papers), Fungal Infections and Studies (29 papers) and Gut microbiota and health (10 papers). Mark S. Gresnigt collaborates with scholars based in Netherlands, Germany and United States. Mark S. Gresnigt's co-authors include Frank L. van de Veerdonk, Mihai G. Netea, Leo A. B. Joosten, Bernhard Hube, Jean‐Paul Latgé, Luigina Romani, J.W.M. van der Meer, Rob J.W. Arts, Charles A. Dinarello and Carol A. Kumamoto and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Communications.

In The Last Decade

Mark S. Gresnigt

74 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Broad defects in the energy metabolism of leukocytes underlie immunoparalysis in sepsis

2016 438 citations Shih‐Chin Cheng, Mark S. Gresnigt et al. profile →
Aspergillus fumigatus morphology and dynamic host interactions

2017 337 citations Frank L. van de Veerdonk, Mark S. Gresnigt et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark S. Gresnigt Netherlands	34	1.7k	1.6k	1.4k	1.2k	274	76	4.2k
David L. Moyes United Kingdom	37	2.1k 1.2×	1.6k 1.0×	788 0.5×	1.1k 0.9×	304 1.1×	85	4.2k
Gerben Ferwerda Netherlands	30	1.2k 0.7×	1.7k 1.0×	2.3k 1.6×	1.3k 1.1×	432 1.6×	85	4.9k
Teruo Kirikae Japan	37	1.3k 0.8×	807 0.5×	1.1k 0.8×	1.5k 1.2×	259 0.9×	191	4.3k
Theo S. Plantinga Netherlands	36	1.2k 0.7×	1.7k 1.1×	1.9k 1.3×	1.2k 1.0×	216 0.8×	92	4.4k
Constantin F. Urban Sweden	27	1.4k 0.8×	1.0k 0.7×	3.0k 2.1×	1.3k 1.1×	480 1.8×	49	4.7k
Jeffrey K. Actor United States	39	1.8k 1.0×	1.3k 0.8×	1.3k 0.9×	895 0.7×	388 1.4×	126	4.6k
Paolo Mosci Italy	33	2.1k 1.2×	1.7k 1.1×	1.3k 0.9×	494 0.4×	237 0.9×	67	3.8k
Shih‐Chin Cheng Netherlands	23	1.2k 0.7×	939 0.6×	1.4k 1.0×	860 0.7×	151 0.6×	39	3.1k
Michael K. Mansour United States	30	1.7k 1.0×	1.5k 0.9×	787 0.5×	1.1k 0.9×	251 0.9×	100	3.6k
Rebecca A. Drummond United Kingdom	26	1.2k 0.7×	1.0k 0.6×	915 0.6×	646 0.5×	129 0.5×	48	2.6k

Countries citing papers authored by Mark S. Gresnigt

Since Specialization

Citations

This map shows the geographic impact of Mark S. Gresnigt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark S. Gresnigt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark S. Gresnigt more than expected).

Fields of papers citing papers by Mark S. Gresnigt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark S. Gresnigt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark S. Gresnigt. The network helps show where Mark S. Gresnigt may publish in the future.

Co-authorship network of co-authors of Mark S. Gresnigt

This figure shows the co-authorship network connecting the top 25 collaborators of Mark S. Gresnigt. A scholar is included among the top collaborators of Mark S. Gresnigt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark S. Gresnigt. Mark S. Gresnigt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hoffmann, Bianca, Mark S. Gresnigt, Vanessa R. Marcelino, et al.. (2025). Deciphering respiratory viral infections by harnessing organ-on-chip technology to explore the gut–lung axis. Open Biology. 15(3). 240231–240231. 1 indexed citations

Wagener, Jeanette, Xiaowen Wang, Katharina L. Becker, et al.. (2025). Immunomodulatory function of chitosan is dependent on complement receptor 3. PubMed. 14. 100146–100146. 2 indexed citations

Mosig, Alexander S., Katja Graf, Martin Raasch, et al.. (2024). Modeling of intravenous caspofungin administration using an intestine-on-chip reveals altered Candida albicans microcolonies and pathogenicity. Biomaterials. 307. 122525–122525. 8 indexed citations

Jaeger, Martin, Axel Dietschmann, Larsen Vornholz, et al.. (2024). Alpha1-antitrypsin impacts innate host–pathogen interactions with Candida albicans by stimulating fungal filamentation. Virulence. 15(1). 2333367–2333367. 6 indexed citations

Zelante, Teresa, et al.. (2024). Inflammatory cytokine signalling in vulvovaginal candidiasis: a hot mess driving immunopathology. PubMed. 5(1). iqae010–iqae010. 14 indexed citations

Gresnigt, Mark S., et al.. (2024). Hyphal‐associated protein expression is crucial for Candida albicans ‐induced eicosanoid biosynthesis in immune cells. European Journal of Immunology. 54(3). 3 indexed citations

Vij, Raghav, Hue Dinh, Peter R. Judzewitsch, et al.. (2024). A synthetic peptide mimic kills Candida albicans and synergistically prevents infection. Nature Communications. 15(1). 16 indexed citations

Møller, Lars, Peter Großmann, Katja Graf, et al.. (2022). Lactobacillus rhamnosus colonisation antagonizes Candida albicans by forcing metabolic adaptations that compromise pathogenicity. Nature Communications. 13(1). 3192–3192. 64 indexed citations

Matzaraki, Vasiliki, Martin Jaeger, Mark S. Gresnigt, et al.. (2022). Genetic determinants of fungi-induced ROS production are associated with the risk of invasive pulmonary aspergillosis. Redox Biology. 55. 102391–102391. 5 indexed citations

10.

Akoumianaki, Tonia, Katerina Vaporidi, Frédéric Pène, et al.. (2021). Uncoupling of IL-6 signaling and LC3-associated phagocytosis drives immunoparalysis during sepsis. Cell Host & Microbe. 29(8). 1277–1293.e6. 35 indexed citations

11.

Alonso‐Monge, Rebeca, Mark S. Gresnigt, Elvira Román, Bernhard Hube, & Jesús Plá. (2021). Candida albicans colonization of the gastrointestinal tract: A double-edged sword. PLoS Pathogens. 17(7). e1009710–e1009710. 51 indexed citations

12.

Pekmezović, Marina, Sejeong Lee, Nessim Kichik, et al.. (2021). Albumin Neutralizes Hydrophobic Toxins and Modulates Candida albicans Pathogenicity. mBio. 12(3). e0053121–e0053121. 25 indexed citations

13.

Pekmezović, Marina, Selene Mogavero, Hrant Hovhannisyan, et al.. (2021). Human albumin enhances the pathogenic potential of Candida glabrata on vaginal epithelial cells. PLoS Pathogens. 17(10). e1010037–e1010037. 14 indexed citations

14.

Graaf, Dennis M. de, Sanne P. Smeekens, Elan Eisenmesser, et al.. (2020). Human recombinant interleukin-38 suppresses inflammation in mouse models of local and systemic disease. Cytokine. 137. 155334–155334. 22 indexed citations

15.

Gresnigt, Mark S., Evelien G. G. Sprenkeler, Jacques F. Meis, et al.. (2018). Adjunctive interferon-γ immunotherapy in a pediatric case of Aspergillus terreus infection. European Journal of Clinical Microbiology & Infectious Diseases. 37(10). 1915–1922. 9 indexed citations

16.

Becker, Katharina L., Vishukumar Aimanianda, Mark S. Gresnigt, et al.. (2016). Aspergillus Cell Wall Chitin Induces Anti- and Proinflammatory Cytokines in Human PBMCs via the Fc-γ Receptor/Syk/PI3K Pathway. mBio. 7(3). 58 indexed citations

17.

Delsing, Corine, Mark S. Gresnigt, Jenneke Leentjens, et al.. (2014). Interferon-gamma as adjunctive immunotherapy for invasive fungal infections: a case series. BMC Infectious Diseases. 14(1). 166–166. 177 indexed citations

18.

Smeekens, Sanne P., Mark S. Gresnigt, Katharina L. Becker, et al.. (2014). An anti-inflammatory property of Candida albicans β-glucan: Induction of high levels of interleukin-1 receptor antagonist via a Dectin-1/CR3 independent mechanism. Cytokine. 71(2). 215–222. 42 indexed citations

19.

Gresnigt, Mark S., Leo A. B. Joosten, Ineke Verschueren, et al.. (2012). Neutrophil-Mediated Inhibition of Proinflammatory Cytokine Responses. The Journal of Immunology. 189(10). 4806–4815. 60 indexed citations

20.

Smeekens, Sanne P., Stefanie Henriet, Mark S. Gresnigt, et al.. (2011). Low Interleukin-17A Production in Response to Fungal Pathogens in Patients with Chronic Granulomatous Disease. Journal of Interferon & Cytokine Research. 32(4). 159–168. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact